Tarsus Pharmaceuticals, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Irvine, CA
TARS chart
What traders are saying about $TARS
Latest postsTarsus Pharmaceuticals, Inc. news
- Earnings Preview: Tarsus Pharmaceuticals, Inc. (TARS) Q3 Earnings Expected to Decline
Yahoo Finance ·
- INDV Stock Price and Chart — NASDAQ:INDV
TradingView ·
- (TARS) Volatility Zones as Tactical Triggers
Stock Traders Daily ·
- Tarsus Pharmaceuticals Stock In Focus After Large Share Shelf Filings
Simply Wall Street ·
- Tarsus Pharmaceuticals, Inc. Estimates – NASDAQ:TARS
TradingView ·
- Tarsus Pharmaceuticals (TARS) Ticks Up 0.79% to $71.06 as Buyers Hold the Line Above Support - NAAIM Exposure
https://www.siam.in/ ·
- Lisata adds biopharma finance veteran Jeffrey Farrow to board
proactiveinvestors.com ·
- Lisata Therapeutics Appoints Jeff Farrow to Board of Directors
Yahoo Finance ·
- Tarsus Plans to Present 11 Abstracts Highlighting New Insights in Demodex Blepharitis, Ocular Rosacea and the Real-World Impact of XDEMVY at the American Academy of Optometry 2026 Annual Meeting
Yahoo Finance ·
- When To Dump Stocks: These IBD 50 Components Hit Sell Signals
Yahoo Finance ·
- Tarsus Pharmaceuticals Completes Acquisition of Alkeus Pharmaceuticals, Expanding Leadership in Eye Care
Yahoo Finance ·
- Tarsus to Participate in Upcoming Investor Conferences
Yahoo Finance ·
Tarsus Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $451.4M | $183.0M | $17.4M | $25.8M |
| Net income | -$66.0M | -$116.0M | -$136.0M | -$62.1M |
| Diluted EPS | $-1.59 | $-3.07 | $-4.62 | $-2.52 |
| Total assets (year end) | $562.2M | $377.0M | $265.5M | $227.9M |
| Cash and equivalents (year end) | $183.6M | $94.8M | $224.9M | $71.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Tarsus Pharmaceuticals, Inc.
- Ticker
- TARS (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Irvine, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1819790
Frequently asked questions
What exchange is Tarsus Pharmaceuticals, Inc. listed on?
Tarsus Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol TARS.
What industry is Tarsus Pharmaceuticals, Inc. in?
Tarsus Pharmaceuticals, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Tarsus Pharmaceuticals, Inc. headquartered?
Tarsus Pharmaceuticals, Inc.'s business address on file with the SEC is in Irvine, CA.
When does Tarsus Pharmaceuticals, Inc.'s fiscal year end?
Tarsus Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Tarsus Pharmaceuticals, Inc. report?
Tarsus Pharmaceuticals, Inc. reported $451.4M in revenue for calendar year 2025, according to its SEC filings.